losartan has been researched along with Constriction, Pathologic in 8 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of losartan in the prevention of restenosis after BD of esophageal stenosis in children with DEB." | 8.31 | Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa. ( Abaykhanov, R; Budkina, T; Dyakonova, E; Fisenko, A; Gusev, A; Lokhmatov, M; Murashkin, N; Oldakovskiy, V; Tupylenko, A; Yatzik, S, 2023) |
| "To evaluate the efficacy of losartan in the prevention of restenosis after BD of esophageal stenosis in children with DEB." | 4.31 | Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa. ( Abaykhanov, R; Budkina, T; Dyakonova, E; Fisenko, A; Gusev, A; Lokhmatov, M; Murashkin, N; Oldakovskiy, V; Tupylenko, A; Yatzik, S, 2023) |
| "Losartan treatment improved PVS-associated pulmonary hypertension and intimal hyperplasia and might be a beneficial prophylactic therapy for patients at high risk of developing PVS after pulmonary vein surgery." | 3.80 | Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis. ( Caldarone, CA; Coles, JG; Fu, YY; Ide, H; Kato, H; Maynes, JT; Teichert, AM; Weisel, RD; Zhu, J, 2014) |
| "67 Mb heterozygous deletion including the Eln gene, presented with a generalized arteriopathy, hypertension, and cardiac hypertrophy, associated with elevated angiotensin II (angII), oxidative stress parameters, and Ncf1 expression." | 3.78 | Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome. ( Bustelo, XR; Campuzano, V; Coustets, M; Francke, U; Menacho-Márquez, M; Nevado, J; Pérez-Jurado, LA; Sánchez-Rodríguez, C; Segura-Puimedon, M; Terrado, V, 2012) |
| "The pulmonary vasoconstriction induced by acute hypoxia was significantly attenuated during losartan infusion, while Psa, SVR, CO, pH, PaCO(2), PaO(2) and base excess did not differ between groups." | 3.74 | The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets. ( Bancalari, E; Camelo, JS; Camelo, SH; Devia, C; Hehre, D; Suguihara, C, 2008) |
| " The aim of this study was to investigate the role of angiotensin II (Ang II), a major inducer of cardiac hypertrophy, in the reexpression of T-type channel in left ventricular hypertrophied myocytes." | 3.72 | Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. ( Capuano, V; Coulombe, A; Deroubaix, E; Ferron, L; Renaud, JF; Ruchon, Y, 2003) |
| "We have established a reproducible stenosis model in hypercholesterolemic hamsters, and the process of arterial stenosis by thrombus or neointima was studied and compared with that in normal hamsters." | 1.31 | Characterization of simple and reproducible vascular stenosis model in hypercholesterolemic hamsters. ( Abe, A; Kozawa, O; Matsuno, H; Niwa, M; Takiguchi, Y; Uematsu, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Oldakovskiy, V | 1 |
| Murashkin, N | 1 |
| Lokhmatov, M | 1 |
| Gusev, A | 1 |
| Tupylenko, A | 1 |
| Budkina, T | 1 |
| Yatzik, S | 1 |
| Dyakonova, E | 1 |
| Abaykhanov, R | 1 |
| Fisenko, A | 1 |
| Zhu, J | 1 |
| Ide, H | 1 |
| Fu, YY | 1 |
| Teichert, AM | 1 |
| Kato, H | 1 |
| Weisel, RD | 1 |
| Maynes, JT | 1 |
| Coles, JG | 1 |
| Caldarone, CA | 1 |
| Lee, S | 1 |
| Harris, NR | 1 |
| Campuzano, V | 1 |
| Segura-Puimedon, M | 1 |
| Terrado, V | 1 |
| Sánchez-Rodríguez, C | 1 |
| Coustets, M | 1 |
| Menacho-Márquez, M | 1 |
| Nevado, J | 1 |
| Bustelo, XR | 1 |
| Francke, U | 1 |
| Pérez-Jurado, LA | 1 |
| Ferron, L | 1 |
| Capuano, V | 1 |
| Ruchon, Y | 1 |
| Deroubaix, E | 1 |
| Coulombe, A | 1 |
| Renaud, JF | 1 |
| Camelo, JS | 1 |
| Hehre, D | 1 |
| Devia, C | 1 |
| Camelo, SH | 1 |
| Bancalari, E | 1 |
| Suguihara, C | 1 |
| Koide, M | 1 |
| Carabello, BA | 1 |
| Conrad, CC | 1 |
| Buckley, JM | 1 |
| DeFreyte, G | 1 |
| Barnes, M | 1 |
| Tomanek, RJ | 1 |
| Wei, CC | 1 |
| Dell'Italia, LJ | 1 |
| Cooper, G | 1 |
| Zile, MR | 1 |
| Matsuno, H | 1 |
| Kozawa, O | 1 |
| Niwa, M | 1 |
| Abe, A | 1 |
| Takiguchi, Y | 1 |
| Uematsu, T | 1 |
8 other studies available for losartan and Constriction, Pathologic
| Article | Year |
|---|---|
Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa.
Topics: Adolescent; Child; Child, Preschool; Constriction, Pathologic; Epidermolysis Bullosa; Epidermolysis | 2023 |
Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antigens, CD; Cadherins; Constri | 2014 |
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Blood Flow Velocity; C | 2008 |
Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.
Topics: Acetophenones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Blood Pre | 2012 |
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Bosentan; Butadienes; C | 2003 |
The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Animals, Newborn | 2008 |
Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pr | 1999 |
Characterization of simple and reproducible vascular stenosis model in hypercholesterolemic hamsters.
Topics: Animals; Becaplermin; Blood Flow Velocity; Carotid Arteries; Carotid Artery Thrombosis; Cells, Cultu | 2001 |